PMK 001 Lowers Cholesterol
Natural health product licensed in Canada
- Licence holder
- PMK Federal Regulatory Consultants Ltd.
- NPN or DIN-HM
- 80032805
- Status
- Active licence
- Licence date
- 14 June 2012
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Trigonella foenum-graecum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Allium sativum Source : Bulbe Extraction ratio : 10:1 Dry plant equivalent : 500 milligramme | 50 milligramme | Not calculated |
| Trigonella foenum-graecum Source : Graine(s) Extraction ratio : 20:1 Dry plant equivalent : 2,000 milligramme | 100 milligramme | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Eau distillée, Huile de soja
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Capsule ; maximum: 2 Capsule | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
Used in Herbal Medicine to help reduce elevated blood lipid levels in adults. Used in Herbal Medicine to help reduce hyperlipidaemia in adults. Helps maintain healthy cholesterol levels and lower blood total LDL cholesterol.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you have diabetes, or are taking blood thinners or protease inhibitors.
- Contre-indications
Hypersensitivity (e.g. allergy) has been known to occur; in which case discontinue use.
Source
Official Health Canada record, licence 80032805
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.